← All indications
Hyperplasia
An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
Drugs by status
Approved for this indication (1)
Phase 4 trials (4)
Phase 3 trials (9)
Phase 2 trials (10)
Phase 1 trials (7)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (72)
- Pierre Fabre
- Roche
- Astellas
- Recordati
- Merck
- Eli Lilly
- Pfizer
- Sanofi
- Biocinese
- Bioforce AG
- Chiesi
- Dong-A Pharmaceutical
- GlaxoSmithKline
- Handok Pharmaceuticals Co., Ltd.
- JW Pharmaceutical
- Solvay
- Boehringer Ingelheim
- United States Navy
- University of Roma La Sapienza
- Maternite Regionale Universitaire
- Siami, Paul F., M.D.
- Dr. Sami Ulus Children's Hospital
- Chungbuk National University
- University of London
- Doctors Hospital at Renaissance
- University of Washington
- I.M. Sechenov First Moscow State Medical University
- Inje University
- Korea University
- Kocatepe University
- +42 more
Organization Involved with Phase 3 Indications (77)
- Sanofi-Synthelabo
- ICOS
- Wyeth
- Anesiva, Inc.
- Apsen Farmaceutica S.A.
- Diurnal Limited
- GL Pharm Tech Corporation
- Health Ever Bio-Tech Co., Ltd.
- Jeil Pharmaceutical Co., Ltd.
- Mallinckrodt
- Materia Medica Holding
- Neurocrine Biosciences
- Nymox Corporation
- Sophiris Bio Corp
- Threshold Pharmaceuticals
- Chong Kun Dang Pharmaceutical
- IlDong Pharmaceutical Co Ltd
- Vantia Ltd
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- United States Army
- Baylor University
- Emory University
- Hanyang University
- Henry Ford Health System
- +47 more
Organization Involved with Phase 2 Indications (67)
- Novelion Therapeutics
- Incyte
- Spectrum Pharmaceuticals
- Takeda
- Novartis
- Allergan
- American Medical Systems
- Bayer
- Edimer Pharmaceuticals
- Kissei Pharmaceuticals
- Kael-GemVax Co., Ltd.
- Light Sciences Oncology
- Milkhaus Laboratory
- Millendo Therapeutics, Inc.
- Mundipharma
- Tasly Pharmaceuticals, Inc.
- innoVactiv Inc.
- Ausio Pharmaceuticals, LLC
- Medipost Co Ltd.
- Transition Therapeutics
- French National Agency for Research on AIDS and Viral Hepatitis
- National Center for Research Resources (NCRR)
- National Institute of Dental and Craniofacial Research (NIDCR)
- Warner Chilcott
- University of Arizona
- Barzilai Medical Center
- Benha University
- Brown University
- Tzu Chi University
- Cairo University
- +37 more
Organization Involved with Phase 1 Indications (35)
- Bristol-Myers Squibb
- Centocor
- BTG
- Dongkook Pharmaceutical Co., Ltd.
- Yuyu Pharma, Inc.
- AIDS Malignancy Consortium
- Dong-A University
- Manchanda Medical Clinic
- Shanghai University of Traditional Chinese Medicine
- Universidad Complutense de Madrid
- University of Ottawa
- Vinmec International Hospital
- Yonsei University
- University of California, Irvine
- Icahn School of Medicine at Mount Sinai
- Department of Defense
- Hammersmith Medicines Research
- Beni Suef University
- Boryung Pharmaceutical Company
- Cha Medical University
- University of Texas, Galveston
- University of North Carolina at Chapel Hill
- State University of New York, Buffalo
- Canadian Institutes of Health Research (CIHR)
- Fundación de Ayuda a la Investigación sobre la Hipertensión pulmonar
- Isotrace Technologies
- Pomegranate Health
- Jarrow Pharmaceuticals
- China Medical University
- Ontario Institute for Regenerative Medicine (OIRM)
- +5 more
Organization Involved with Other Experimental Indications (16)
- Applied Biology, Inc.
- Franklin D. Gaylis, MD Inc.
- University of Pittsburgh
- Kaohsiung Medical University
- Kocaeli University
- Medical College of Wisconsin
- Radboud University
- Saint-Joseph University
- Sanford Health
- University of Pavia
- Urology of Virginia
- Chinese University of Hong Kong
- Golden Biotechnology Corp.
- University of Sao Paulo
- Government of Hong Kong
- Corpometria Institute